Anthony Florence Insider Profile
11 Followers
Anthony Florence, Ten Percent Owner at Oruka Therapeutics, holds 1.30M shares in Korro Bio (Ticker: KRRO), holds 7.39M shares in SpyGlass Pharma (Ticker: SGP), holds 0.00 shares in NeueHealth Inc (Ticker: NEUE). Most recently, Anthony Florence Bought ― shares of Korro Bio on Mar 12, 2026 for an estimated value of $2.30M.
Anthony Florence Oruka Therapeutics (ORKA)Ten Percent Owner
Oruka Therapeutics (ORKA)
Ten Percent Owner
Ranked #101,690 out of 106,487 Corporate Insiders
Profitable Transactions
16 out of 65 Profitable Transactions
Average Return
-16.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anthony Florence holds in companies
Most Profitable Insider Trade
Stock:
Achaogen
(AKAOQ)
(AKAOQ)
Rating:Informative Buy
Date:Jun 07, 2016 - Jun 07, 2017
Return:+423.70%
The most profitable trade made by Anthony Florence
Anthony Florence's Trading History
Oruka Therapeutics
Feb 27, 2018
Ten Percent Owner
Informative Sell
730.10K
$0.00
Adaptimmune Therapeutics
Jan 28, 2020
Ten Percent Owner
Informative Buy
4.95M
$2.05M
AVEO Pharma
Oct 21, 2022
―
Uninformative Buy
―
$5.31K
Achaogen
Dec 19, 2016
―
Informative Buy
6.75M
$117.88K
Cascadian Therapeutics
Mar 13, 2018
―
Uninformative Sell
―
$0.00
Regulus
May 09, 2019
―
Informative Buy
1.23M
$16.75M
Appian
Feb 15, 2018
Ten Percent Owner
Uninformative Buy
―
$387.09K
Synlogic
Jan 26, 2018
Ten Percent Owner
Uninformative Buy
4.00M
$2.52M
Surface Oncology
Apr 23, 2018
―
Uninformative Buy
―
$3.54M
Mulesoft Inc
May 09, 2018
―
Uninformative Sell
―
$0.00
Genocea Biosciences
May 26, 2022
Ten Percent Owner
Informative Sell
711.52K
―
Trevi Therapeutics
Apr 13, 2022
Ten Percent Owner
Informative Buy
6.80M
$135.76M
Mirum Pharmaceuticals
Jun 15, 2023
Ten Percent Owner
Uninformative Buy
―
$206.98M
Casper Sleep
Jun 14, 2021
―
Uninformative Buy
―
$42.41M
Mersana Therapeutics
Sep 16, 2020
―
Uninformative Buy
―
$173.69M
AKOUOS
Dec 02, 2022
―
Uninformative Sell
―
$0.00
Nkarta
Jul 16, 2020
Ten Percent Owner
Uninformative Buy
―
$6.73M
Inozyme Pharma
Jul 28, 2020
―
Uninformative Buy
―
$9.75M
Metacrine
Dec 27, 2021
―
Informative Sell
493.91K
$1.49M
Eargo
May 26, 2021
―
Uninformative Buy
―
$11.62M
NeueHealth Inc
Oct 06, 2025
―
Uninformative Buy
11.15K
$0.00
Monte Rosa Therapeutics
Jun 30, 2021
Ten Percent Owner
Uninformative Buy
―
$131.46M
Robinhood
May 04, 2022
Director
Uninformative Buy
―
$1.64B
IonQ
Nov 18, 2022
Ten Percent Owner
Uninformative Buy
―
$428.25M
Arcellx Inc
Dec 22, 2022
Ten Percent Owner
Uninformative Buy
―
$544.61M
Savara
Jul 19, 2023
Ten Percent Owner
Informative Buy
1000.00K
$136.06M
Korro Bio
Mar 12, 2026
Ten Percent Owner
Informative Buy
2.30M
$18.17M
MBX Biosciences, Inc.
Sep 17, 2024
Ten Percent Owner
Uninformative Buy
―
$119.24M
SpyGlass Pharma
Feb 11, 2026
Ten Percent Owner
Uninformative Buy
―
$166.03M
Ardelyx
Dec 09, 2019
Ten Percent Owner
Uninformative Buy
2.50M
$38.99M
TRACON Pharmaceuticals
Mar 27, 2018
―
Informative Buy
1.91M
$110.91K
Loxo Oncology
Aug 06, 2014
―
Uninformative Buy
―
$419.91M
Care
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Anthony Florence's performance on stock
You May Also Like
Anthony Florence insider profile FAQ
What is the percentage of profitable transactions made by Anthony Florence?
The percentage of profitable transactions made by Anthony Florence is 25%.
What is the average return per transaction made by Anthony Florence?
The average return per transaction made by Anthony Florence is -16.40%.
What stocks does Anthony Florence hold?
Anthony Florence holds: ORKA, ADAPY, AVEO, AKAOQ, CASC, RGLS, APPN, SYBX, SURF, MULE, GNCAQ, TRVI, MIRM, CSPR, MRSN, AKUS, NKTX, INZY, MTCR, EAR, NEUE, GLUE, HOOD, IONQ, ACLX, SVRA, KRRO, MBX, SGP, ARDX, TCON, LOXO, CRCM stocks.
What was Anthony Florence’s latest transaction?
Anthony Florence latest transaction was an Informative Buy of $2.30M.
What was Anthony Florence's most profitable transaction?
Anthony Florence’s most profitable transaction was an Informative Buy of AKAOQ stock on June 7, 2016. The return on the trade was 423.70%.
What is Anthony Florence's role in Oruka Therapeutics?
Anthony Florence's role in Oruka Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.